NCT00097747View on ClinicalTrials.gov

Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
AnemiaChronic Kidney DiseaseChronic Renal FailureCancer
Interventions
DRUG

Placebo

DRUG

peginesatide

Trial Locations (1)

HA1 3UJ

Research Facility, London

Sponsors

Lead Sponsor

Affymax
All Listed Sponsors
lead

Affymax

INDUSTRY